Do SGLT2 inhibitors prevent preclinical diabetic retinopathy? A Prospective Pilot Optical Coherence Tomography Angiography Study

Autor:	Mehmet Dogan, R. Duman, S. Beysel, A. Vurmaz, M. Akdogan, Mehmet Cem Sabaner, E. Bozkurt
Rok vydání:	2021
Předmět:	medicine.medical_specialty endocrine system diseases Urology chemistry.chemical_compound Diabetes mellitus Empagliflozin medicine Humans Prospective Studies Fluorescein Angiography Sodium-Glucose Transporter 2 Inhibitors Glycemic Diabetic Retinopathy business.industry digestive oral and skin physiology Retinal Vessels nutritional and metabolic diseases Type 2 Diabetes Mellitus Retinal Diabetic retinopathy Optical coherence tomography angiography medicine.disease Metformin Ophthalmology Diabetes Mellitus Type 2 chemistry business Tomography Optical Coherence medicine.drug
Zdroj:	Journal Français d'Ophtalmologie. 44:1159-1167
ISSN:	0181-5512
DOI:	10.1016/j.jfo.2021.01.005
Popis:	PURPOSE To evaluate the effects of metformin alone and combined treatment with metformin and an SGLT2 inhibitor on retinal microvascular morphology using optical coherence tomography angiography (OCTA) in isolated type 2 diabetes mellitus (DM) patients with HbA1c above the expected target (>7%). METHODS Fifty patients with isolated DM, 7%
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddc2b3d6bcaf157fa3b3aef6d333def7 https://doi.org/10.1016/j.jfo.2021.01.005 Zobrazit plný text záznamu